Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Ottawa Hospital Research Institute
Federico II University
Queen's University, Belfast
University Health Network, Toronto
Herlev Hospital
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University Hospital, Bordeaux
Odense University Hospital
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University Hospital, Geneva
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
University Hospital, Bordeaux
Fred Hutchinson Cancer Center
Mayo Clinic
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Mayo Clinic
University of Utah
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
M.D. Anderson Cancer Center
Swiss Cancer Institute
Icahn School of Medicine at Mount Sinai
University Hospital, Brest
Wake Forest University Health Sciences
Icahn School of Medicine at Mount Sinai
OHSU Knight Cancer Institute
Icahn School of Medicine at Mount Sinai
UNC Lineberger Comprehensive Cancer Center
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Icahn School of Medicine at Mount Sinai
Yale University
Hospital Israelita Albert Einstein
Alliance for Clinical Trials in Oncology
Northside Hospital, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indiana University
Memorial Sloan Kettering Cancer Center
Asan Medical Center